Effect of analgesia using buccal fentanyl versus diclofenac suppository for extracorporeal shock wave lithotripsy

Open-label randomised controlled study of efficacy of buccal fentanyl versus diclofenac suppository analgesia for extracorporeal shock wave lithotripsy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN75580529

Enrollment

100

Registered

2013-11-06

Start date

2012-08-01

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain associated with extracorporeal shock wave lithotripsy treatment is due to repetitive shockwave applied to body surface. Signs and Symptoms Pain

Interventions

Randomised single-blind controlled trial comparing two interventions - buccal fentanyl versus oral diclofenac analgesia for ESWL. One group will receive 100mcg of buccal fentanyl and second group will

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing extracorporeal shock wave lithotripsy in Bedford Hospital NHS Trust

Exclusion criteria

Exclusion criteria: 1. Patient's refusal to be included in the trial 2. Allergy or adverse reaction to fentanyl or diclifenac 3. Contraindications to fentanyl or diclofenac

Design outcomes

Primary

Measure	Time frame
Pain measured on Visual Analogue Scale score (0= No pain, 10=Unbearable pain)	—

Secondary

Measure	Time frame
Presence of adverse reactions to buccal fentanyl or oral diclofenac	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026